The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors (GIST) as ≥4th line therapy: Long-term update from a single-arm, phase 2 trial.
 
Jian Li
No Relationships to Disclose
 
Xinhua Zhang
No Relationships to Disclose
 
Yongjian Zhou
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Ye Zhou
No Relationships to Disclose
 
Ming Wang
No Relationships to Disclose
 
Xin Wu
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Zhao Huang
Employment - Zai Lab
Stock and Other Ownership Interests - Zai Lab
 
Juan Dong
Employment - Zai Lab
Stock and Other Ownership Interests - Zai Lab
 
Lin Shen
No Relationships to Disclose